Former President Jimmy Carter has died at the age of 100. The 39th president of the United States was a Georgia peanut farmer who sought to restore trust in government when he assumed the presidency in 1977 and then built a reputation for tireless work as a humanitarian. He earned a Nobel Peace Prize in 2002. He died Sunday, more than a year after entering hospice care, at his home in Plains, Georgia. At age 52, Carter was sworn in as president on Jan. 20, 1977, after defeating President Gerald R. Ford in the 1976 general election. Carter left office on Jan. 20, 1981, following his 1980 general election loss to Ronald Reagan. Here's the latest: The longest-lived American president died Sunday, more than a year after entering hospice care , at his home in the small town of Plains, Georgia, where he and his wife, Rosalynn, who died at 96 in November 2023 , spent most of their lives. “Our founder, former U.S. President Jimmy Carter, passed away this afternoon in Plains, Georgia,” The Carter Center said in posting about his death on the social media platform X. It added in a statement that he died peacefully, surrounded by his family. In his 1975 book “Why Not The Best,” Carter said of himself: “I am a Southerner and an American, I am a farmer, an engineer, a father and husband, a Christian, a politician and former governor, a planner, a businessman, a nuclear physicist, a naval officer, a canoeist, and among other things a lover of Bob Dylan’s songs and Dylan Thomas’s poetry.” A moderate Democrat, Carter entered the 1976 presidential race as a little-known Georgia governor with a broad smile, outspoken Baptist mores and technocratic plans reflecting his education as an engineer. After he left office and returned home to his tiny hometown of Plains in southwest Georgia, Carter regularly taught Sunday School lessons at Maranatha Baptist Church until his mobility declined. Those sessions drew visitors from around the world. Former Vice President Al Gore praised Jimmy Carter for living “a life full of purpose, commitment and kindness” and for being a “lifelong role model for the entire environmental movement.” Carter, who left the White House in 1981 after a landslide defeat to Ronald Reagan. concentrated on conflict resolution, defending democracy and fighting disease in the developing world. Gore, who lost the 2000 presidential election to George W. Bush, remains a leading advocate for action to fight climate change. Both won Nobel Peace Prizes. Gore said that “it is a testament to his unyielding determination to help build a more just and peaceful world” that Carter is often “remembered equally for the work he did as President as he is for his leadership over the 42 years after he left office.” During Gore’s time in the White House, President Bill Clinton had an uneasy relationship with Carter. But Gore said he is “grateful” for “many years of friendship and collaboration” with Carter. Former President Bill Clinton and his wife, former Secretary of State Hillary Clinton, remember Carter as a man who lived to serve others. “Hillary and I mourn the passing of President Jimmy Carter and give thanks for his long, good life. Guided by his faith, President Carter lived to serve others — until the very end." The statement recalled Carter's many achievements and priorities, including efforts “to protect our natural resources in the Arctic National Wildlife Refuge, make energy conservation a national priority, return the Panama Canal to Panama, and secure peace between Egypt and Israel at Camp David." After he left office, the Clinton statement said, Carter continued efforts in "supporting honest elections, advancing peace, combating disease, and promoting democracy; to his and Rosalynn’s devotion and hard work at Habitat for Humanity — he worked tirelessly for a better, fairer world,” the statement said.Atletico Madrid conceded three goals in a Spanish league game for the first time this season but still managed to beat Sevilla 4-3, with Antoine Griezmann's double helping make it nine wins in a row for Diego Simeone's in-form side. Third-placed Madrid restored their three-point lead over fourth-placed Athletic Bilbao, who beat Villarreal earlier on Sunday (Monday AEDT). Rodrigo De Paul gave Atletico the perfect start when he lashed home a stunning opener in the 10th minute. However, goals from Dodi Lukebakio, Isaac Romero and Juanlu Sanchez put Sevilla 3-1 up early in the second half and Atletico, without the vocal support of some home fans in a dispute over tickets, seemed lost in an unusually quiet Metropolitano Stadium. Simeone's side, though, is known for its resilience and it was not long before the fightback began. Griezmann reduced the deficit in the 62nd minute, and 17 minutes later, after Simeone made five substitutions in a quarter of an hour, Samuel Lino got the equaliser with a low shot from 30 yards. Griezmann got the winner in stoppage time to consolidate Atletico's third place. The Madrid club now has 35 points, one behind city rivals Real and three behind league leaders Barcelona. "We struggled to get into the game," Griezmann said. "We missed the support of the fans behind the goal, but in the end we managed to come back." Athletic Bilbao consolidated fourth place with a comfortable 2-0 win over Villarreal, the team immediately below them in the table and one of their closest rivals for a Champions League spot. Aitor Paredes put Athletic ahead when he glanced home a corner kick in 14 minutes, and Inaki Williams made it 2-0 midway through the second half. It was the fourth consecutive league win for Athletic, but the victory was marred by a silent protest from an organised fan group. The group refused to sing or chant in response to a rift between it and the club president, who reported threats to police last week. Several Athletic players expressed solidarity with the president, and the team did not salute the fans behind the goal after the match. "It's a very sad win and a time for everyone to pull together," club captain Oscar De Marcos said in comments reported by newspaper Marca. "The silence was notable during the game but we need to keep doing our job." Earlier on Sunday, Real Sociedad won for the fourth time in a row, beating Leganes 3-0 at the Butarque stadium near Madrid. Three days after his extra-time goal gave Sociedad a 1-0 win at fourth-tier Conquense in the Copa del Rey, Brais Mendez scored again to give the visitors an early lead. Substitute Ander Barrenetxea's first goal of the league season doubled their lead 10 minutes from time, then Mikel Oyarzabal added a third in stoppage time. It was only the fourth time in 16 matches that Sociedad have scored twice in a league game, and the win lifted them into sixth, above Osasuna, who drew 2-2 with Alaves. It only took 37 seconds for Kike Garcia to put Alaves ahead with a diving header. However, Ante Budimir and Ruben Garcia scored early in the second half to put Osasuna in front, before Kike Garcia got his second to tie the scores at 2-2. The point was the first for new Alaves coach Eduardo Coudet, but leaves the side in 15th place without a win in five games.
Kalyan assembly election results 2024: Who is winning in Kalyan East, West and Rural?
AMD shares dip 2% amid AWS AI chip demand concernsNEW YORK, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the closing of its underwritten public offering of 13,690,000 shares of its common stock at a public offering price of $6.25 per share and pre-funded warrants to purchase 2,325,372 shares of common stock at a price of $6.249 per pre-funded warrant, which represents the per share price for the common stock less the $0.001 per share exercise price for each such pre-funded warrant. In addition, Protara has granted the underwriters a 30-day option to purchase up to an additional 2,402,305 shares of common stock at the public offering price, less underwriting discounts and commissions. The gross proceeds from the offering were approximately $100 million before deducting underwriting discounts and commissions and offering expenses payable by Protara and excluding any exercise of the underwriters’ option to purchase additional shares and the exercise of any pre-funded warrants. Protara intends to use the net proceeds received from the offering to fund the clinical development of TARA-002, as well as the development of other clinical programs. Protara may also use the net proceeds from the offering for working capital and other general corporate purposes. TD Cowen, Cantor, LifeSci Capital, Oppenheimer & Co. and Scotiabank acted as joint book-running managers of the offering. The shares of common stock and the pre-funded warrants were issued pursuant to an effective shelf registration statement on Form S-3 (File No. 333-275290) that was declared effective on November 14, 2023 by the U.S. Securities and Exchange Commission. The offering was made only by means of a prospectus supplement and the accompanying prospectus. Copies of the final prospectus supplement and the accompanying prospectus relating to the offering may be obtained from the offices of TD Securities (USA) LLC, 1 Vanderbilt Avenue, New York, New York 10017, by email at TD.ECM_Prospectus@tdsecurities.com or by telephone at (855) 495-9846; Cantor Fitzgerald & Co., 110 East 59th Street, 6th Floor, New York, New York 10022, Attention: Capital Markets, or by email at prospectus@cantor.com; or LifeSci Capital LLC, 1700 Broadway, 40th Floor, New York, New York 10019, or by email at compliance@lifescicapital.com. This press release shall not constitute an offer to sell or a solicitation of an offer to buy any of these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the applicable securities laws of such state or jurisdiction. Forward-looking Statements Statements contained in this press release regarding matters that are not historical facts are “forward looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Protara may, in some cases, use terms such as “predicts,” “believes,” “potential,” “proposed,” “continue,” “designed,” “estimates,” “anticipates,” “expects,” “plans,” “intends,” “may,” “could,” “might,” “will,” “should” or other words or expressions referencing future events, conditions or circumstances that convey uncertainty of future events or outcomes to identify these forward-looking statements. Investors are cautioned that any forward-looking statements, including statements regarding the expected use of proceeds therefrom, are not guarantees of future performance or results and involve substantial risks and uncertainties. Actual results, developments and events may differ materially from those in the forward-looking statements as a result of various factors including Protara’s expectations related to the use of proceeds from the offering. Additional important factors to be considered in connection with forward-looking statements, including additional risks and uncertainties, are described more fully under the caption “Risk Factors” and elsewhere in Protara’s filings and reports with the Securities and Exchange Commission. All forward-looking statements contained in this press release speak only as of the date on which they were made. Protara undertakes no obligation to update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise, except as required by law. Company Contact: Justine O'Malley Protara Therapeutics Justine.OMalley@protaratx.com 646-817-2836Special counsel moves to drop federal cases against Trump